Today, our vaccines are safer and more efficacious than the inoculations of 1777, and they keep advancing largely due to a ...
A research team led by Director Kim V. Narry at the Center for RNA Research within the Institute for Basic Science (IBS) has discovered compact viral RNA elements that can make mRNA more stable and ...
A technology has been developed that extends the lifespan of messenger ribonucleic acid (mRNA) by approximately three times by leveraging an RNA prote ...
Scientists at the Center for Molecular Medicine Cologne (CMMC) and the CECAD Cluster of Excellence on Aging Research have demonstrated in a biomedical study that ribosomes, the protein factories of ...
Dr Débora Broch Trentini Schmidt [email protected] ...
RNA technology is moving beyond vaccines to enable targeted gene-editing therapies and novel treatments for complex diseases, ...
Operator: Good day, and thank you for standing by. Welcome to the Moderna Second Quarter 2026 Conference Call. Please be ...
GC Green Cross announced on August 7, 2026, that research results providing a precise analysis of the physicochemical ...
Tempest’s TPST-4003 is a next-generation in vivo CAR-T candidate combining proprietary CD7-targeted mRNA/LNP delivery with a dual-target ...
Detailed price information for Cartesian Therapeutics Inc (RNAC-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results